Actively Recruiting

Phase 4
Age: 21Years +
All Genders
Healthy Volunteers
NCT04552080

The Effect of Systemic Antibiotics on Post-surgical Complications and Patient-centered Outcomes in Patients Undergoing Implant Surgery With Guided Bone Regeneration and Simultaneous Sinus Floor Elevation

Led by Medical University of Graz · Updated on 2024-07-03

30

Participants Needed

1

Research Sites

165 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The primary aim of the trial is to evaluate the effect of systemic antibiotic administration compared to placebo in patients undergoing oral implant therapy with simultaneous lateral sinus floor elevation and guided bone regeneration (GBR) in regard to patient-centered outcomes. The secondary aims of the trial is to evaluate the effect of systemic antibiotic administration on postsurgical complications, in patients undergoing oral implant therapy with simultaneous lateral approach sinus floor elevation and guided bone regeneration (GBR).

CONDITIONS

Official Title

The Effect of Systemic Antibiotics on Post-surgical Complications and Patient-centered Outcomes in Patients Undergoing Implant Surgery With Guided Bone Regeneration and Simultaneous Sinus Floor Elevation

Who Can Participate

Age: 21Years +
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Medically healthy adults classified as ASA I-II, aged 21 years or older
  • Non-smokers, previous smokers who quit at least 5 years ago, or light smokers with fewer than 10 cigarettes per day
  • No allergies to amoxicillin, penicillin antibiotics, NSAIDs, or corn starch
  • Presence of edentulous spaces in the posterior maxilla needing sinus floor elevation and allowing placement of up to 3 dental implants with simultaneous guided bone regeneration
  • No signs of sinus membrane pathology or acute sinusitis requiring ongoing care
Not Eligible

You will not qualify if you...

  • Medically compromised individuals classified as ASA III-V
  • General contraindications to implant or augmentation procedures, including immunodeficiency, advanced systemic diseases, or corticosteroid use
  • Current use of bisphosphonates, anti-angiogenic, or RANKL inhibitor medications, or receiving local radiotherapy
  • Heavy smokers or those who quit less than 5 years ago, smoking 10 or more cigarettes per day
  • Allergies to amoxicillin, penicillin antibiotics, NSAIDs, or corn starch
  • Use of any antibiotics in the last 3 months or requiring regular antibiotic prophylaxis before dental treatment
  • Pregnant or breastfeeding women or those intending to conceive
  • Need for two-stage sinus augmentation
  • Acute or unmanaged symptomatic sinusitis
  • Immediate implant placement following extraction (Type 1 implant placement)
  • Need for simultaneous soft tissue augmentation
  • Residual bone height greater than 5 mm
  • Individuals younger than 21 years old

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Medical University of Graz, University Hospital for Dentistry and Oral Health

Graz, Austria, 8010

Actively Recruiting

Loading map...

How is the study designed?

Study Type

INTERVENTIONAL

Masking

DOUBLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here